Note: Ingredients listed on restricted chemical lists
EC/CAS
231-595-7/7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
**
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
**
EC/CAS
202-785-7/99-76-3
Name of the chemical
4-hydroxybenzoic acid, methyl ester
Concentration
*
General Information
Version
1.1
Revision date
2016-11-11
Product name
Bupivacaine Injection
Product Synonyms
Bupivacaine Spinal (Bupivacine in Dextrose, USP)
Chemical name
Not determined
1.2.1 Relevant identified uses
Pharmaceutical product used as anesthetic agent
Emergency telephone
1-800-424-9300, +1-703-527-3887
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Classification of the Substance or Mixture GHS - Classification Acute Oral Toxicity: Category 4
Signal word
Warning
Hazard statements
H302 - Harmful if swallowed
Precautionary statements
P264 - Wash hands thoroughly after handling P270 - Do not eat, drink or smoke when using this product P301+ P312 - IF SWALLOWED: Call a POISON CENTRE or doctor/physician if you feel unwell P330 - Rinse mouth P501 - Dispose of contents/container in accordance with all local and national regulations
2.3 Other hazards
An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8). Note This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
2.1 Classification of the substance or mixture
GHS - Classification Acute Oral Toxicity: Category 4
